111 related articles for article (PubMed ID: 15274391)
1. 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis.
Turhal NS; Dane F; Dede F; Gumus M; Yumuk PF; Cakalagaoglu F; Savci D; Karaman M; Gulluoglu B; Turoglu HT
Anticancer Res; 2004; 24(3b):1999-2006. PubMed ID: 15274391
[TBL] [Abstract][Full Text] [Related]
2. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
3. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
5. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
Lee JK; Kao CH; Sun SS
Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
[TBL] [Abstract][Full Text] [Related]
9. Identification of angiogenesis in primary breast carcinoma according to the image analysis.
Kim SW; Park SS; Ahn SJ; Chung KW; Moon WK; Im JG; Yeo JS; Chung JK; Noh DY
Breast Cancer Res Treat; 2002 Jul; 74(2):121-9. PubMed ID: 12186372
[TBL] [Abstract][Full Text] [Related]
10. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
11. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters].
Dimonte M; Leo G; Marsigliante S; Manca C
Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
14. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
Alonso O; Massardo T; Delgado LB; Horvath J; Kabasakal L; Llamas-Olier A; Maunda KK; Morales R; Padhy AK; Shankar UR
J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629
[TBL] [Abstract][Full Text] [Related]
15. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
16. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
Bach-Gansmo T; Danielsson R; Saracco A; Wilczek B; Bogsrud TV; Fangberget A; Tangerud A; Tobin D
J Nucl Med; 2006 Sep; 47(9):1434-9. PubMed ID: 16954550
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
18. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
19. Scintimammography with 99mTc-MDP: experience of the National Cancer Institute of Naples.
Piccolo S; Lastoria S; Thomas R; Muto P; Apicella A; Petrosino T; Cortino G; D'Aiuto G; Ziviello M
Eur J Radiol; 1998 May; 27 Suppl 2():S275-81. PubMed ID: 9652535
[TBL] [Abstract][Full Text] [Related]
20. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]